Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.
How to buy Phreesia stock | 32.8
Own Phreesia stock in just a few minutes.
Phreesia, Inc is a health information services business based in the US. Phreesia shares (PHR) are listed on the NYSE and all prices are listed in US Dollars. Phreesia employs 532 staff and has a trailing 12-month revenue of around USD$134.1 million.
How to buy shares in Phreesia
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Phreesia Find the stock by name or ticker symbol: PHR. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Phreesia reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of USD$32.8, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Phreesia, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Phreesia. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Phreesia share price
Use our graph to track the performance of PHR stocks over time.Phreesia shares at a glance
Information last updated 2020-10-16.
| Latest market close | USD$32.8 |
|---|---|
| 52-week range | USD$16.01 - USD$34.85 |
| 50-day moving average | USD$30.8474 |
| 200-day moving average | USD$28.145 |
| Wall St. target price | USD$35 |
| PE ratio | 2.3646 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-35.448 |
Compare trading platforms
Compare special offers, low fees and a wide range of types of investments among top trading platforms.The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Phreesia stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Phreesia price performance over time
Historical closes compared with the close of $32.8 from 2020-10-16
| 1 week (2020-10-12) | 1.71% |
|---|---|
| 1 month (2020-09-18) | 9.85% |
| 3 months (2020-07-17) | 12.44% |
| 6 months (2020-04-17) | 50.18% |
| 1 year (2019-10-18) | 17.02% |
|---|---|
| 2 years (2018-10-16) | N/A |
| 3 years (2017-10-16) | N/A |
| 5 years (2015-10-16) | N/A |
Is Phreesia under- or over-valued?
Valuing Phreesia stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phreesia's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Phreesia's P/E ratio
Phreesia's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 2x. In other words, Phreesia shares trade at around 2x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Phreesia financials
| Revenue TTM | USD$134.1 million |
|---|---|
| Gross profit TTM | USD$80.1 million |
| Return on assets TTM | -7.03% |
| Return on equity TTM | -18.54% |
| Profit margin | -13.87% |
| Book value | $2.579 |
| Market capitalisation | USD$1.3 billion |
TTM: trailing 12 months
Shorting Phreesia shares
There are currently 1.4 million Phreesia shares held short by investors – that's known as Phreesia's "short interest". This figure is 101.5% up from 689,280 last month.
There are a few different ways that this level of interest in shorting Phreesia shares can be evaluated.
Phreesia's "short interest ratio" (SIR)
Phreesia's "short interest ratio" (SIR) is the quantity of Phreesia shares currently shorted divided by the average quantity of Phreesia shares traded daily (recently around 505130.18181818). Phreesia's SIR currently stands at 2.75. In other words for every 100,000 Phreesia shares traded daily on the market, roughly 2750 shares are currently held short.
However Phreesia's short interest can also be evaluated against the total number of Phreesia shares, or, against the total number of tradable Phreesia shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Phreesia's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Phreesia shares in existence, roughly 40 shares are currently held short) or 0.0481% of the tradable shares (for every 100,000 tradable Phreesia shares, roughly 48 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Phreesia.
Find out more about how you can short Phreesia stock.
Phreesia share dividends
We're not expecting Phreesia to pay a dividend over the next 12 months.
Phreesia overview
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company's Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. It deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a Web-based dashboard for providers; PhreesiaPads, which are self-service intake tablets; and Arrivals Stations that are on-site kiosks. The company's Phreesia Platform also provides a registration solution to automate patient self-registration; patient activation solution that enables providers to communicate with their patients through surveys, announcements, messaging, and health campaigns; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; clinical support solution that collects clinical intake and PRO data for approximately 25 specialties; appointments solution for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and life sciences, pharmaceutical, medical device, and biotechnology companies. Phreesia, Inc. has a strategic alliance agreement with Allscripts Healthcare, LLC. The company was founded in 2005 and is headquartered in New York, New York.
Frequently asked questions
Ask an Expert